Last reviewed · How we verify
NCT07399379: RACAR
Augmented Reality as Discharge Information for Hospitalized Cardiology Patients
NA trial testing Augmented reality app in Myocardial Infarction (MI) in 303 participants. Completed in 29 December 2025.
16 December 2025
Quick facts
| Lead sponsor | Hospital Universitario Getafe |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 303 |
| Start date | 23 February 2024 |
| Primary completion | 16 December 2025 |
| Estimated completion | 29 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Augmented reality app
Conditions studied
- Myocardial Infarction (MI) — all drugs for Myocardial Infarction (MI) →
- Pacemaker Implantation — all drugs for Pacemaker Implantation →
- Heart Failure — all drugs for Heart Failure →
- Atrial Fibrillation (AF) — all drugs for Atrial Fibrillation (AF) →
Sponsor
Hospital Universitario Getafe
Who can join
18 and older, any sex, with Myocardial Infarction (MI) or Pacemaker Implantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. This study includes adult patients who are admitted to a cardiology department because of: * Ischaemic heart disease * Atrial fibrillation * Heart failure * Or who need a pacemaker implantation The main questions this study aims to answer are: * Does providing augmented reality information at discharge improve patients' perceived quality of care? * Does it improve patients' adherence to their prescribed treatment? * Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death? Researchers will compare two groups of participants: * A control group, who will receive the usual medical discharge report. * An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application. Participants will: * Receive their discharge information according to the group they are assigned to. * Use the augmented reality application if they are in the intervention group. * Be followed over time to assess treatment adherence, patient experience, and cardiovascular events. This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07399379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Infarction (MI)
Currently open trials in the same condition.
- NCT07052799 — Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/o · Phase 3 · recruiting
- NCT07320625 — Efficacy of Montelukast on STEMl Patients · Phase 3 · recruiting
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07137936 — Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY · recruiting
- NCT07243769 — A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergo · NA · recruiting
Other Hospital Universitario Getafe trials
Trials by the same sponsor.
- NCT07447453 — Motivational Support for an Autonomous Exercise Program for Healthy Aging · NA · recruiting
- NCT05392010 — Global BurdEn of MechanIcal VeNtilatIon (GEMINI). VeNtilatIon (GEMINI Study) 2022 for VENTILAGROUP. · unknown
- NCT05032885 — Early Physiotherapy in Covid Patients · NA · completed
- NCT04379258 — Analysis of Mortality of Critically Ill Patients With COVID-19 · completed
- NCT04592146 — Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07399379 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Getafe
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07399379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing